CNBC’s Angelica Peebles and Eli Lilly CEO David Ricks join 'Squawk Box' to discuss the company's quarterly earnings results, Mounjaro and Zepbound sales growth, launch of the company's GLP-1 pill ...

Foundayo's success will surely be a headline-grabber for Lilly, burnishing the pharmaceutical giant's reputation. After ...

More than just a simple rise, the pharmaceutical company's stock has been re-evaluated due to a growth narrative that ...

At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Lilly CEO Dave Ricks ...

Eli Lilly and Company (NYSE:LLY) was among the stocks on which Jim Cramer gave his opinion, as he warned that increased ...

At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Lilly CEO Dave Ricks ...

Eli Lilly CEO Dave Ricks is pulling back from Germany, cutting a $2.3 billion commitment in half, and pointing the freed ...

Eli Lilly (NYSE: LLY | LLY Price Prediction) and Novo Nordisk (NYSE: NVO) reported Q1 2026 results that pulled the GLP-1 ...

Eli Lilly may look at manufacturing its weight-loss drug Mounjaro in India in future as it expands its global footprint, CEO David Ricks, who is visiting the country, has said. His comments come days ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Mounjaro is displayed in a pharmacy in Provo (Reuters) - U.S. drugmaker Eli Lilly expects its blockbuster weight-loss ...

John Lechleiter, who led Eli Lilly and Co. through a painful period of job cuts and patent expirations while steering toward new products, will retire at the end of the year. Lechleiter will step down ...

Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government ...